# Open Label Study, Assessing the Effect of Diltiazem or Ketoconazole on the Pharmacokinetics of AZD9742 in Healthy Volunteers

> **NCT01124760** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 28 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** AZD9742
- **DRUG:** Diltiazem
- **DRUG:** ketoconazole

## Key facts

- **NCT ID:** NCT01124760
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2010-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01124760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01124760, "Open Label Study, Assessing the Effect of Diltiazem or Ketoconazole on the Pharmacokinetics of AZD9742 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01124760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
